Volume 137, Issue 1, Pages (July 2009)

Slides:



Advertisements
Similar presentations
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Advertisements

a GM DM1 DM3 DM5 DM7 b MHC MHC +DAPI GM DM4
Volume 131, Issue 4, Pages (October 2006)
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 143, Issue 3, Pages e2 (September 2012)
Crucial Roles of MZF1 and Sp1 in the Transcriptional Regulation of the Peptidylarginine Deiminase Type I Gene (PADI1) in Human Keratinocytes  Sijun Dong,
Volume 132, Issue 5, Pages (May 2007)
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Volume 138, Issue 1, Pages e3 (January 2010)
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 128, Issue 1, Pages (January 2005)
Volume 138, Issue 3, Pages e2 (March 2010)
PTF1α/p48 and cell proliferation
Volume 140, Issue 7, Pages (June 2011)
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 137, Issue 2, Pages (August 2009)
Zara E Khan, Timothy C Wang, Guanglin Cui, Alfred L Chi, Rod Dimaline 
Volume 138, Issue 2, Pages (February 2010)
Volume 145, Issue 2, Pages e6 (August 2013)
Volume 135, Issue 5, Pages e3 (November 2008)
Increased Expression of Hepatocyte Nuclear Factor 6 Stimulates Hepatocyte Proliferation During Mouse Liver Regeneration  Yongjun Tan, Yuichi Yoshida,
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 133, Issue 1, Pages (July 2007)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
Volume 136, Issue 2, Pages (February 2009)
The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo  Loning Fu, Helene Pelicano, Jinsong Liu, Peng.
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
M. Ushita, T. Saito, T. Ikeda, F. Yano, A. Higashikawa, N. Ogata, U
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 11, Issue 4, Pages (April 2010)
Volume 23, Issue 7, Pages (July 2015)
Volume 53, Issue 3, Pages (September 2010)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 127, Issue 4, Pages (October 2004)
Volume 127, Issue 1, Pages (July 2004)
ATF5 transactivates Egr-1 via the ATF5CON sites in the Egr-1 promoter.
Volume 130, Issue 4, Pages (August 2007)
Volume 8, Issue 6, Pages (December 2010)
MiTF Regulates Cellular Response to Reactive Oxygen Species through Transcriptional Regulation of APE-1/Ref-1  Feng Liu, Yan Fu, Frank L. Meyskens  Journal.
Volume 135, Issue 3, Pages e3 (September 2008)
Yin-Yang 1 Negatively Regulates the Differentiation-Specific Transcription of Mouse Loricrin Gene in Undifferentiated Keratinocytes  Xuezhu Xu, Yasuhiro.
Volume 129, Issue 5, Pages (November 2005)
Volume 132, Issue 4, Pages (April 2007)
Andrew W Snowden, Philip D Gregory, Casey C Case, Carl O Pabo 
Volume 14, Issue 5, Pages (November 2011)
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
Volume 16, Issue 24, Pages (December 2006)
Volume 128, Issue 3, Pages (March 2005)
Volume 142, Issue 4, Pages e4 (April 2012)
Volume 134, Issue 1, Pages (January 2008)
Volume 127, Issue 4, Pages (October 2004)
Volume 126, Issue 4, Pages (April 2004)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Volume 39, Issue 5, Pages (November 2003)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 10, Issue 9, Pages (May 2000)
Volume 128, Issue 7, Pages (June 2005)
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
Defining the Regulatory Elements in the Proximal Promoter of ΔNp63 in Keratinocytes: Potential Roles for Sp1/Sp3, NF-Y, and p63  Rose-Anne Romano, Barbara.
Mammalian SIRT1 Represses Forkhead Transcription Factors
Volume 31, Issue 6, Pages (December 2009)
Volume 72, Issue 2, Pages (July 2007)
Volume 16, Issue 5, Pages (May 2009)
Targeting DCLK1 by miRNA-137.
Volume 125, Issue 2, Pages (August 2003)
Presentation transcript:

Volume 137, Issue 1, Pages 330-340 (July 2009) Y-Box Binding Protein-1 Down-Regulates Expression of Carbamoyl Phosphate Synthetase-I by Suppressing CCAAT Enhancer-Binding Protein-Alpha Function in Mice  Yen–Rong Chen, Keisuke Sekine, Koji Nakamura, Hiroyuki Yanai, Minoru Tanaka, Atsushi Miyajima  Gastroenterology  Volume 137, Issue 1, Pages 330-340 (July 2009) DOI: 10.1053/j.gastro.2009.02.064 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Expression of YB-1 during mouse fetal liver development. (A) Expression of various mRNA as shown during liver development by Northern blot analysis. RNA was prepared from mouse liver tissues at E14.5, E17.5, the neonatal period, and 4- and 8-week-old mice. (B) Protein levels of YB-1, C/EBPα isoforms (p42 and p30), CPS1, and β-actin during liver development. The protein levels in whole cell extracts from the liver at different stages were examined by Western blot analysis. (C) Expression of mRNA in fetal hepatic cultures. E14.5 fetal liver cells were cultured and RNA was prepared for Northern blot. (D) Protein levels of YB-1, CPS1, and β-actin in fetal hepatic cultures. Mouse E14.5 fetal liver cells were cultured and protein was prepared for Western blot analysis. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 The effect of YB-1 on CPS1 expression and ammonia clearance in mouse fetal liver cells. (A) YB-1 was expressed using a retroviral system in the fetal liver culture. The levels of mRNA of CPS1, cyclin A, G6Pase, TAT, GS, YB-1, and GAPDH at 7 days after the infection were examined by Northern blot analysis. (B) The ammonia and urea production levels in the culture medium of fetal liver culture. The medium was changed to the one containing ammonia 3 days after the retroviral infection and the ammonia and urea levels were determined at different time points as indicated. Because serum in the culture medium contained urea, the data shown are urea produced during culture, that is, the serum urea level was subtracted from the amount of urea measured in the cultured media. The ability of the cells overexpressing YB-1 to metabolize ammonia was less than that of control cells. Error bars represent + standard deviations. *P < .05. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Suppression of transcription from the CPS1 promoter by YB-1. (A) The distal enhancer and proximal enhancer of the CPS1 gene promoter. (B) Structure of pGL4-CPS1 (proximal)-Luc vector. (C) Structure of pGL4-CPS1 (distal–proximal)-Luc vector. 293T cells were transfected with the CPS1 promoter-Luc vectors together with the expression vectors for C/EBPα, GR, and YB-1 as indicated. Cells were harvested for luciferase assays 48 hours after transfection. Data shown are normalized by Renilla luciferase activity and are mean values + standard deviations. A representative experiment performed in triplicate is shown. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Suppression of transcription from the CPS1 promoter via Y-box site. (A) Nucleotide sequence of the promoter region of the CPS1 gene. There is an inverted CCAAT sequence at position −90 from the transcription start site of the CPS1 promoter and the C/EBPα binding site is between −104 and −117. The Y-box was mutated to TTTTT (Y-box mutant 1) and TCTCT (Y-box mutant 2). (B) C/EBPα and pGL4-CPS1 (proximal)-Luc plasmids were co-transfected into 293T cells with either CPS1 (proximal)-Luc (WT), Y-box mutant 1-Luc (mut1), or Y-box mutant 2-Luc (mut2) and luciferase activity was measured 48 hours later. (C) Wild-type, mut1, or mut2 was transfected with C/EBPα and YB-1 expression vectors as indicated and luciferase activity was measured 48 hours later. Data shown are normalized by Renilla luciferase activity and are mean values + standard deviations. A representative experiment performed in triplicate is shown. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Recruitment of YB-1 in liver. Recruitment of C/EBPα and YB-1 to the target DNA demonstrated by chromatin immunoprecipitation assays. The association of C/EBPα and YB-1 with the endogenous CPS1 promoter (−300∼−50) was detected by chromatin immunoprecipitation assays as described in Materials and Methods. The β-actin promoter fragment (−75∼+252) failed to recruit C/EBPα and YB-1, indicating specific recruitment of these proteins to the CPS1 promoter. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Expression and recruitment of YB-1 in CCl4-impaired liver. (A) Expression of mRNA and protein in CCl4-induced liver injury. CCl4 was injected into the peritoneum of mice. RNA and protein were prepared from livers at different time points after the injection. The RNA and protein levels were determined by Northern and Western blot analyses. The level of YB-1 was increased at 24 hours after CCl4 treatment, whereas the expression of CPS1 RNA decreased to an undetectable level at the same time point. The CPS1 protein level began to decrease at 24 hours after CCl4 treatment. (B) The concentration of ammonia in serum was measured. The level began to rise from 24 hours after CCl4 treatment, and reached a peak at 48 hours. The concentration of serum urea was measured. The level reached the lowest point at 48 hours. Error bars represent + standard deviations. N = 4–6. *P < .003; #P < .002. (C) Recruitment of C/EBPα and YB-1 to the target DNA demonstrated by chromatin immunoprecipitation assays. (D) Acetaminophen was injected into the peritoneum of mice and RNA was prepared from liver at different time points after the injection. RNA levels were determined by Northern blot analysis. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions

Figure 7 Role of YB-1 in CPS1 expression and ammonia detoxification. YB-1 is highly expressed in fetal liver and down-regulated along with differentiation, whereas C/EBPα is constitutively expressed. YB-1 is absent in normal adult liver, but is expressed in injured liver. In contrast, CPS1 is absent in fetal liver and expressed in normal liver. CPS1 expression is down-regulated in injured liver, accompanying hyperammonemia. Gastroenterology 2009 137, 330-340DOI: (10.1053/j.gastro.2009.02.064) Copyright © 2009 AGA Institute Terms and Conditions